Yu Pu

540 total citations
38 papers, 398 citations indexed

About

Yu Pu is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Epidemiology. According to data from OpenAlex, Yu Pu has authored 38 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Epidemiology. Recurrent topics in Yu Pu's work include MRI in cancer diagnosis (5 papers), Nanoparticle-Based Drug Delivery (5 papers) and Liver Disease Diagnosis and Treatment (5 papers). Yu Pu is often cited by papers focused on MRI in cancer diagnosis (5 papers), Nanoparticle-Based Drug Delivery (5 papers) and Liver Disease Diagnosis and Treatment (5 papers). Yu Pu collaborates with scholars based in China, Bulgaria and Singapore. Yu Pu's co-authors include Xiao Ming Zhang, Yong Tao, Jiang Zhu, Guo‐Qiang Zhang, Tian‐wu Chen, Shun Huang, Changqiang Wu, Conghui Yang, Yunchao Huang and Long Chen and has published in prestigious journals such as Chemical Communications, Organic Letters and RSC Advances.

In The Last Decade

Yu Pu

37 papers receiving 394 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu Pu China 12 90 89 65 58 55 38 398
Susan K. Brusnahan United States 12 102 1.1× 84 0.9× 65 1.0× 52 0.9× 32 0.6× 18 449
Shinichi Ohta Japan 13 105 1.2× 56 0.6× 65 1.0× 61 1.1× 75 1.4× 55 466
Caterina Malcontenti‐Wilson Australia 13 112 1.2× 107 1.2× 97 1.5× 27 0.5× 106 1.9× 21 426
Adelina Curaj Germany 15 231 2.6× 148 1.7× 137 2.1× 46 0.8× 125 2.3× 30 756
Man Shu China 11 101 1.1× 145 1.6× 121 1.9× 99 1.7× 57 1.0× 25 418
Dyskin Ea United States 11 236 2.6× 63 0.7× 78 1.2× 95 1.6× 66 1.2× 27 649
Michelle Kuzma Canada 12 133 1.5× 135 1.5× 124 1.9× 64 1.1× 52 0.9× 19 509
Hao‐Hao Wang China 11 125 1.4× 71 0.8× 59 0.9× 72 1.2× 37 0.7× 20 327

Countries citing papers authored by Yu Pu

Since Specialization
Citations

This map shows the geographic impact of Yu Pu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Pu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Pu more than expected).

Fields of papers citing papers by Yu Pu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Pu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Pu. The network helps show where Yu Pu may publish in the future.

Co-authorship network of co-authors of Yu Pu

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Pu. A scholar is included among the top collaborators of Yu Pu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Pu. Yu Pu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yang, Hui-Min, Xiaokun Zhao, Xiaoling Li, et al.. (2024). A pan-cancer analysis of the oncogenic function of HMGB1 in human tumors. Biochemistry and Biophysics Reports. 40. 101851–101851. 1 indexed citations
3.
4.
Zhang, Linlin, et al.. (2024). The research focus and frontiers in surgical treatment of essential tremor. Frontiers in Neurology. 15. 1499652–1499652. 1 indexed citations
5.
Wu, Changqiang, Jie Zhong, Yu Pu, et al.. (2024). MRI-guided photothermal/photodynamic immune activation combined with PD-1 inhibitor for the multimodal combination therapy of melanoma and metastases. Regenerative Biomaterials. 11. rbae019–rbae019. 8 indexed citations
6.
Geng, Shasha, et al.. (2024). Advances in disilylation reactions to access cis/trans-1,2-disilylated and gem-disilylated alkenes. Chemical Communications. 60(26). 3484–3506. 3 indexed citations
7.
Zhong, Jie, Yu Pu, Jiang Zhu, et al.. (2023). Dopamine multivalent-modified polyaspartic acid for MRI-guided near-infrared photothermal therapy. Regenerative Biomaterials. 10. rbad022–rbad022. 15 indexed citations
8.
Pu, Yu, et al.. (2023). Superparamagnetic iron oxide nanoparticles target BxPC-3 cells and silence MUC4 for the treatment of pancreatic cancer. Biochimica et Biophysica Acta (BBA) - General Subjects. 1867(9). 130383–130383. 7 indexed citations
9.
Li, Xinghui, Yu Pu, Wei Tang, et al.. (2023). Early assessment of acute kidney injury in severe acute pancreatitis with multimodal DWI: an animal model. European Radiology. 33(11). 7744–7755. 6 indexed citations
10.
Pu, Yu, et al.. (2022). Effect of F11R Gene Knockdown on Malignant Biological Behaviors of Pancreatic Cancer Cells. Journal of Oncology. 2022. 1–8. 2 indexed citations
11.
Deng, Lihua, Yu Pu, Changqiang Wu, et al.. (2021). Size and PEG Length-Controlled PEGylated Monocrystalline Superparamagnetic Iron Oxide Nanocomposite for MRI Contrast Agent. International Journal of Nanomedicine. Volume 16. 201–211. 30 indexed citations
12.
Lin, Jingrong, et al.. (2020). Toripalimab-Induced Dermatomyositis in a Patient with Metastatic Melanoma. Dermatology and Therapy. 10(4). 863–867. 6 indexed citations
13.
Pu, Yu, et al.. (2020). IL10-modified Human Mesenchymal Stem Cells inhibit Pancreatic Cancer growth through Angiogenesis Inhibition. Journal of Cancer. 11(18). 5345–5352. 16 indexed citations
14.
15.
Li, Yong, Changqiang Wu, Tian‐wu Chen, et al.. (2016). Effects of RNAi-mediated MUC4 gene silencing on the proliferation and migration of human pancreatic carcinoma BxPC-3 cells. Oncology Reports. 36(6). 3449–3455. 5 indexed citations
16.
17.
Zhu, Jiang, et al.. (2014). The Effect of Superparamagnetic Iron Oxide with iRGD Peptide on the Labeling of Pancreatic Cancer CellsIn Vitro: A Preliminary Study. BioMed Research International. 2014. 1–8. 28 indexed citations
18.
Zhu, Jianjun, et al.. (2014). FBXL20 acts as an invasion inducer and mediates E-cadherin in colorectal adenocarcinoma. Oncology Letters. 7(6). 2185–2191. 16 indexed citations
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susan K. Brusnahan Breakdown of academic impact, for papers by Shinichi Ohta Breakdown of academic impact, for papers by Caterina Malcontenti‐Wilson Breakdown of academic impact, for papers by Adelina Curaj Breakdown of academic impact, for papers by Man Shu Breakdown of academic impact, for papers by Dyskin Ea Breakdown of academic impact, for papers by Michelle Kuzma Breakdown of academic impact, for papers by Hao‐Hao Wang
Rankless by CCL
2026